|
|
EGFR signaling in osteoarthritis and treatment |
| 1 R01 AG067698-01A1 |
QIN, LING |
NIA |
2020 |
|
|
Pharmacologic Inhibition of PDE11A for Age-Related Memory Disorders |
| 1 R01 AG067836-01 |
ROTELLA, DAVID |
NIA |
2020 |
|
|
Establishing a new genetic mouse model of osteoarthritis |
| 1 R21 AG063534-01A1 |
GRUNWALD, DAVID J |
NIA |
2020 |
|
|
Development of Novel ERRa Selective Agonists as Chemical Probes for the Potential Treatment of Alzheimers Disease |
| 1 R21 AG065657-01 |
ELGENDY, BAHAA ELDIEN |
NIA |
2020 |
|
|
PFOS-induced dopaminergic neurodegeneration across nematode, amphibian, and rodent models |
| 1 R21 AG068787-01 |
CANNON, JASON R |
NIA |
2020 |
|
|
Alzheimers Administrative Supplement - An antisense RNA-mediated regulatory program that drives cancer metastasis |
| 3R01CA240984-02S1 |
GOODARZI, HANI |
NIA |
2020 |
|
|
Alzheimers Administrative Supplement - An antisense RNA-mediated regulatory program that drives cancer metastasis |
| 3R01CA240984-02S1 |
GOODARZI, HANI |
NIA |
2020 |
|
|
Brain Neurotropic Growth Factor Delivery to Prevent and Treat Alzheimers Disease |
| 5R01AG051574-05 |
SINGH, JAGDISH |
NIA |
2020 |
|
|
Traumatic brain injury and Alzheimers disease |
| 5R01AG058621-03 |
CHEN, CHU |
NIA |
2020 |
|
|
Mechanisms of neurodegeneration in a porcine model of diet-induced CVD |
| 5R21AG058837-02 |
LAMON-FAVA, STEFANIA |
NIA |
2020 |
